Monitor for follow-up transactions from other insiders; while this is a modest sale, the timing relative to earnings or clinical developments could signal sentiment. The derivative exercises suggest option expiration or vesting, not necessarily bearish intent.
Price Chart
Executive Summary
Director Theresa Heggie sold 49,933 shares of BioCryst Pharmaceuticals for $504,823 in an open-market transaction. This sale was accompanied by the exercise of derivative securities related to the same share amount, including a non-cash exercise. The total open-market sale represents a modest but notable insider disposition.
Key Financial Metrics
Key Facts
- Director Theresa Heggie sold 49,933 shares at $10.11 per share for total proceeds of $504,823.
- On the same day, she exercised derivative securities for 99,866 shares (two separate exercises: one at $6.30 and one at $0 strike price).
- Only the open-market sale (Form 4 code 'S') represents a cash transaction; the derivative exercises (code 'M') are non-cash events and do not reflect new investment or direct selling pressure.
- Total open-market selling in the past 7 days: $504,823 (one insider). Recent 30-day selling totals $1.9M across two insiders.
Financial Impact
$504,823 in open-market sales by a director
Risk Factors
- Perception of insider selling may weigh on sentiment if not contextualized.
- Further sales from other insiders could indicate broader concern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-BCRX-1774382654020 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $9.07 $10.17 | ▲ +12.13% | ▲ +12.73% | $8.09 (−10.86%) |
Jun 29, 2026 13w ago | 8-K | $9.55 $9.34 | ▼ −2.20% | ▼ −1.92% | $8.09 (−15.34%) |
Jun 12, 2026 15w ago | 8-K | $9.06 $9.91 | ▲ +9.38% | ▲ +10.13% | $8.09 (−10.76%) |
Jun 12, 2026 16w ago | Press Release | $8.70 $10.45 | ▲ +20.11% | ▲ +18.34% | $8.09 (−7.07%) |
May 19, 2026 19w ago | Insider Cluster | $8.74 $8.99 | ▲ +2.86% | ▲ +2.12% | $8.09 (−7.49%) |
May 13, 2026 20w ago | 144 | $9.60 $8.50 | ▼ −11.46% | ▼ −10.85% | $8.09 (−15.78%) |
May 6, 2026 21w ago | 8-K | $8.83 $8.25 | ▼ −6.57% | ▼ −9.35% | $8.09 (−8.44%) |
May 4, 2026 21w ago | 8-K | $9.20 $8.57 | ▼ −6.85% | ▼ −12.49% | $8.09 (−12.12%) |
Apr 23, 2026 23w ago | DEFA14A | $8.94 $8.37 | ▼ −6.38% | ▼ −10.40% | $8.09 (−9.56%) |
Apr 15, 2026 24w ago | Press Release | $9.44 $8.80 | ▼ −6.78% | ▼ −12.82% | $8.09 (−14.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access